Ann-marie Yost, MD | |
9155 Sw Barnes Rd, Suite 440, Portland, OR 97225-6625 | |
(503) 935-8500 | |
(503) 935-8505 |
Full Name | Ann-marie Yost |
---|---|
Gender | Female |
Speciality | Neurosurgery |
Experience | 33 Years |
Location | 9155 Sw Barnes Rd, Portland, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730217704 | NPI | - | NPPES |
1730217704 | Medicaid | WA | |
500614092 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD00036204 (Washington) | Secondary |
207T00000X | Neurological Surgery | MD153921 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence Portland Medical Center | Portland, OR | Hospital |
Providence St Vincent Medical Center | Portland, OR | Hospital |
Providence Willamette Falls Medical Center | Oregon city, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oregon Clinic Pc | 2860390408 | 319 |
News Archive
Federal agencies should assess the safety of genetically altered foods - whether produced by genetic engineering or by other techniques, such as conventional breeding for desirable traits - on a case-by-case basis to determine whether unintended changes in their composition could adversely affect human health, says a new report from the National Academies' National Research Council and Institute of Medicine.
Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration 510(k) clearance for its ear, nose and throat (ENT) Extended Instrument Set. The clearance includes the company's tip-navigated GuideWire, PointerShell instrument adaptor and FlexTube navigated suction and irrigation.
The Associated Press: "Insurer UnitedHealth Group Inc. trumped first-quarter earnings expectations and raised its 2010 profit forecast Tuesday, but a meager stock reaction showed investors haven't forgotten about the recently concluded health care reform push. The Minnetonka, Minn., insurer said it trimmed the percentage of premium revenue it spent on medical bills for its commercial insurance to 79 percent, down from 81 percent in last year's first quarter."
Clovis Oncology, Inc. announced today that the TIGER2 study has commenced with the dosing of the first patient at a U.S. study site.
A new study details the genomic characteristics and descent of a SARS-CoV-2 variant of interest.
› Verified 9 days ago
Entity Name | Oregon Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
Federal agencies should assess the safety of genetically altered foods - whether produced by genetic engineering or by other techniques, such as conventional breeding for desirable traits - on a case-by-case basis to determine whether unintended changes in their composition could adversely affect human health, says a new report from the National Academies' National Research Council and Institute of Medicine.
Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration 510(k) clearance for its ear, nose and throat (ENT) Extended Instrument Set. The clearance includes the company's tip-navigated GuideWire, PointerShell instrument adaptor and FlexTube navigated suction and irrigation.
The Associated Press: "Insurer UnitedHealth Group Inc. trumped first-quarter earnings expectations and raised its 2010 profit forecast Tuesday, but a meager stock reaction showed investors haven't forgotten about the recently concluded health care reform push. The Minnetonka, Minn., insurer said it trimmed the percentage of premium revenue it spent on medical bills for its commercial insurance to 79 percent, down from 81 percent in last year's first quarter."
Clovis Oncology, Inc. announced today that the TIGER2 study has commenced with the dosing of the first patient at a U.S. study site.
A new study details the genomic characteristics and descent of a SARS-CoV-2 variant of interest.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Ann-marie Yost, MD 541 Ne 20th Ave Ste 225, Portland, OR 97232-2895 Ph: (503) 963-2801 | Ann-marie Yost, MD 9155 Sw Barnes Rd, Suite 440, Portland, OR 97225-6625 Ph: (503) 935-8500 |
News Archive
Federal agencies should assess the safety of genetically altered foods - whether produced by genetic engineering or by other techniques, such as conventional breeding for desirable traits - on a case-by-case basis to determine whether unintended changes in their composition could adversely affect human health, says a new report from the National Academies' National Research Council and Institute of Medicine.
Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration 510(k) clearance for its ear, nose and throat (ENT) Extended Instrument Set. The clearance includes the company's tip-navigated GuideWire, PointerShell instrument adaptor and FlexTube navigated suction and irrigation.
The Associated Press: "Insurer UnitedHealth Group Inc. trumped first-quarter earnings expectations and raised its 2010 profit forecast Tuesday, but a meager stock reaction showed investors haven't forgotten about the recently concluded health care reform push. The Minnetonka, Minn., insurer said it trimmed the percentage of premium revenue it spent on medical bills for its commercial insurance to 79 percent, down from 81 percent in last year's first quarter."
Clovis Oncology, Inc. announced today that the TIGER2 study has commenced with the dosing of the first patient at a U.S. study site.
A new study details the genomic characteristics and descent of a SARS-CoV-2 variant of interest.
› Verified 9 days ago
Dibyendu K Ray, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3303 Sw Bond Avenue, Ohsu Ch8n, Portland, OR 97239 Phone: 503-494-4178 | |
Won Hyung Ryu, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3303 S Bond Ave, Portland, OR 97239 Phone: 503-494-4314 | |
Feridun Acar, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4314 | |
Dr. Jos'lyn Iman Woodard, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-6207 | |
Oisin Ruadri O'neill, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 9155 Sw Barnes Rd, Ste 440, Portland, OR 97225 Phone: 503-297-3766 Fax: 503-297-8148 | |
Dr. Thomas Jay Rosenbaum, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2222 Nw Lovejoy, Ste 516, Portland, OR 97210 Phone: 503-229-8470 Fax: 503-274-4849 | |
Dr. Martin Athelstan Baggenstos, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9155 Sw Barnes Rd Ste 440, Portland, OR 97225 Phone: 503-935-8500 Fax: 503-935-8505 |